We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Collaboration for Impact with Our New […]
October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. Key Breast Cancer Facts*: The Importance of Early Detection Early detection can lead to a 99% survival rate**. A […]
We are thrilled to announce Regenesis as a Champion Level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. Regenesis is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain to improve quality of life. […]
Read More… from Announcing Our Renewed Partnership with Regenesis
We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. CSL Behring is a global leader in biotherapeutics, dedicated to improving the quality of life for patients with rare and serious diseases. By partnering with FPN, […]
Read More… from Announcing Our Renewed Partnership with CSL Behring
FPN staff recently celebrated another terrific meeting in Montreal, Quebec, Canada, hosted by the Peripheral Nerve Society from June 22-25. Many research conversations took place, specifically concerning our biobank’s newest discoveries and an update on progress made towards the iMAGiNE Study research project that we fund. We look forward to sharing more details about new research underway in our upcoming […]
Does diabetic peripheral neuropathic pain (DPNP) disrupt your daily life and keep you awake at night despite your current treatment? You are not alone. The NEPTUNE-17 clinical trial, hosted by the Foundation for Peripheral Neuropathy Research Impact’s partner, GSK, offers a potential new option for managing DPNP symptoms. You may be eligible to participate in the trial if you: You will also need […]
Read More… from Join the NEPTUNE-17 clinical trial for Diabetic Peripheral Neuropathic Pain (DPNP)
We are honored to announce that on May 16, 2024, the Foundation for Peripheral Neuropathy (FPN) received an extraordinary and transformational donation of over $660,000. This unprecedented gift, given posthumously, is the largest single contribution in our organization’s history. While the donor has chosen to remain anonymous, we wish to honor and celebrate their remarkable generosity. This substantial gift will […]
Read More… from The Foundation for Peripheral Neuropathy Receives Largest Gift to Date
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Expanding our reach Since our establishment in 2007, FPN has been dedicated to serving […]
Read More… from Announcing Our New Partnership with GlaxoSmithKline (GSK)